Form 10-Q - Quarterly report [Sections 13 or 15(d)]

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT of 1934

 

For the transition period from ____________ to ____________

 

Commission File Number: 1-14310

 

 

GLASSBRIDGE ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

 

Delaware		41-1838504
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)
18 East 50th Street, FL7 New York, New York		10022
(Address of principal executive offices)		(Zip Code)

 

[phone]

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
None		None		None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☒

Smaller reporting company ☒

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 25,170 shares of Common Stock, par value $0.01 per share, were outstanding as of July 31, 2023.

 

 

 

 

 

GLASSBRIDGE ENTERPRISES, INC.

 

TABLE OF CONTENTS

 

	PAGE
PART I. FINANCIAL INFORMATION	3
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)	3
Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2023 and 2022	3
Condensed Consolidated Balance Sheets as of June 30, 2023 and December 31, 2022	4
Condensed Consolidated Statements of Shareholders’ Equity (Deficit) as of June 30, 2023 and 2022	5
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2023 and 2022	6
Notes to Condensed Consolidated Financial Statements	7
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	13
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	18
ITEM 4. CONTROLS AND PROCEDURES	18
PART II. OTHER INFORMATION	19
ITEM 1. LEGAL PROCEEDINGS	19
ITEM 1A. RISK FACTORS	19
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	19
ITEM 3. DEFAULTS UPON SENIOR SECURITIES	19
ITEM 4. MINE SAFETY DISCLOSURES	19
ITEM 5. OTHER INFORMATION	19
ITEM 6. EXHIBITS	19
SIGNATURE	20
EX-31.1
EX-31.2
EX-32.1
EX-32.2

 

2

Table of Contents

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

GLASSBRIDGE ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except for share and per share amounts)

(Unaudited)

 

		Three Months Ended								Six Months Ended
		June 30,								June 30,
		2023				2022				2023				2022
Net revenue		$	—			$	—			$	0.1			$	—
Operating expenses:
Selling, general and administrative			1.1				0.8				2.2				1.6
Total operating expenses			1.1				0.8				2.2				1.6
Operating loss			(1.1	)			(0.8	)			(2.1	)			(1.6	)
Other income (expense):
Interest expense			(0.1	)			—				(0.2	)			(0.1	)
Other income, net			0.1				0.1				0.1				0.2
Total other income (expense)			—				0.1				(0.1	)			0.1
Loss before income taxes			(1.1	)			(0.7	)			(2.2	)			(1.5	)
Net loss			(1.1	)			(0.7	)			(2.2	)			(1.5	)
Net loss per common share — basic and diluted:		$	(41.66	)		$	(26.52	)		$	(83.33	)		$	(56.82	)
Weighted average common shares outstanding:
Basic and diluted (thousands)			26.4				26.4				26.4				26.4

 

The accompanying Notes to Condensed Consolidated Financial Statements are an integral part of these statements.

 

3

Table of Contents

 

GLASSBRIDGE ENTERPRISES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except share and per share amounts)

 

		June 30,				December 31,
		2023				2022
		(unaudited)
Assets
Current assets:
Cash and cash equivalents		$	0.2			$	1.2
Accounts receivable, net			—				0.1
Other current assets			0.3				—
Total current assets			0.5				1.3
Investment in Arrive, cost (See Note 5 – Arrive Investment)			12.5				12.8
Other assets and other investments (See Note 5 – Arrive Investment)			0.6				0.5
Total assets		$	13.6			$	14.6
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable		$	2.2			$	1.2
Other current liabilities			0.4				0.4
Total current liabilities			2.6				1.6
GHI LLC note payable (See Note 6 – Debt)			3.9				3.7
Deferred tax liabilities			0.2				0.2
Total liabilities			6.7				5.5
Shareholders’ equity:
Preferred stock, $.01 par value, authorized 200,000 shares, none issued and outstanding			—				—
Common stock, $.01 par value, authorized 50,000, 28,097 issued at June 30, 2023; 28,097 issued at December 31, 2022			—				—
Additional paid-in capital			1,073.0				1,073.0
Accumulated deficit			(1,041.2	)			(1,039.0	)
Treasury stock, at cost: 2,927 shares at June 30, 2023; 2,927 shares at December 31, 2022			(24.9	)			(24.9	)
Total shareholders’ equity			6.9				9.1
Total liabilities and shareholders’ equity		$	13.6			$	14.6

 

The accompanying Notes to Condensed Consolidated Financial Statements are an integral part of these statements.

 

4

Table of Contents

 

GLASSBRIDGE ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(In millions, except share amounts)

(Unaudited)

 

		Common Stock								Additional Paid-in				Accumulated				Treasury Stock								Total Shareholders’
		Shares				Amount				Capital				Deficit				Shares				Amount				Equity
Balance as of December 31, 2022			28,097			$	—			$	1,073.0			$	(1,039.0	)			2,927			$	(24.9	)		$	9.1
Net loss															(2.2	)											(2.2	)
Balance as of June 30, 2023			28,097			$	—			$	1,073.0			$	(1,041.2	)			2,927			$	(24.9	)		$	6.9

 

		Common Stock								Additional Paid-in				Accumulated				Treasury Stock								Total Shareholders’
		Shares				Amount				Capital				Deficit				Shares				Amount				Equity
Balance as of December 31, 2021			28,097			$	—			$	1,073.0			$	(1,036.0	)			2,927			$	(24.9	)		$	12.1
Net loss															(1.5	)											(1.5	)
Balance as of June 30, 2022			28,097			$	—			$	1,073.0			$	(1,037.5	)			2,927			$	(24.9	)		$	10.6

 

The accompanying Notes to Condensed Consolidated Financial Statements are an integral part of these statements.

 

5

Table of Contents

 

GLASSBRIDGE ENTERPRISES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

 

		Six Months Ended
		June 30,
		2023				2022
Cash Flows from Operating Activities:
Net loss		$	(2.2	)		$	(1.5	)
Adjustments to reconcile net loss to net cash used in operating activities:
Payment-in-Kind interest			0.2				0.1
Changes in operating assets and liabilities			1.0				0.1
Net cash used in operating activities			(1.0	)			(1.3	)
Cash Flows from Investing Activities:
Purchase of investments			—				(0.2	)
Net cash used in investing activities			—				(0.2	)
Cash Flows from Financing Activities:
Net cash provided by financing activities			—				—
Net change in cash and cash equivalents			(1.0	)			(1.5	)
Cash and cash equivalents — beginning of period			1.2				4.1
Cash and cash equivalents — end of period		$	0.2			$	2.6
Supplemental disclosures of cash paid during the period:
Interest expense		$	—			$	0.1
Non-cash investing and financing activities during the period:
Marketable securities received from Arrive distribution		$	0.3			$	—
Offset accounts receivable from Arrive vs capital contribution due Arrive			0.1			$	—

  

The accompanying Notes to Condensed Consolidated Financial Statements are an integral part of these statements.

 

6

Table of Contents

 

GLASSBRIDGE ENTERPRISES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1 — Basis of Presentation

 

GlassBridge Enterprises, Inc. (“GlassBridge”, the “Company”, “we”, “us” or “our”) owns and operates an asset management business through various subsidiaries.

 

The interim Condensed Consolidated Financial Statements of GlassBridge are unaudited but, in the opinion of management, reflect all adjustments necessary for a fair statement of financial position, results of operations, comprehensive loss and cash flows for the periods presented. Except as otherwise disclosed herein, these adjustments consist of normal and recurring items. The results of operations for any interim period are not necessarily indicative of full year results. The Condensed Consolidated Financial Statements and Notes are presented in accordance with the requirements for Quarterly Reports on Form 10-Q and do not contain certain information included in our annual Consolidated Financial Statements and Notes presented in accordance with the requirements of Annual Reports on Form 10-K.

 

The interim Condensed Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, and entities in which the Company owns or controls fifty percent or more of the voting shares or interest in such entity, and has the right to control. The results of entities disposed of are included in the unaudited Condensed Consolidated Financial Statements up to the date of the disposal and, where appropriate, these operations have been reflected as discontinued operations. All inter-company balances and transactions have been eliminated in consolidation and, in the opinion of management, all adjustments necessary for a fair presentation have been included in the interim results reported.

 

The preparation of the interim Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses for the reporting periods. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.

 

The December 31, 2022 Condensed Consolidated Balance Sheet data was derived from the audited Consolidated Financial Statements, but does not include all disclosures required by GAAP. This Form 10-Q should be read in conjunction with our Consolidated Financial Statements and Notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on April 7, 2023.

 

Note 2 — New Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

 

Note 3 —Income (Loss) per Common Share

 

Basic income per common share is calculated using the weighted average number of shares outstanding for the period. Unvested restricted stock and treasury shares are excluded from the calculation of weighted average number of common shares outstanding in all cases. Once restricted stock vests, it is included in our common shares outstanding.

 

Diluted income per common share is computed on the basis of the weighted average shares outstanding plus the dilutive effect of our stock-based compensation plans, using the “treasury stock” method.

 

The Company has 1,360 shares of outstanding and exercisable stock options that have been excluded because they would be anti-dilutive. See Note 7 –Stock-Based Compensation for additional information on the stock options.

 

7

Table of Contents

 

The following table sets forth the computation of weighted average basic and diluted income per share (unaudited):

 

		Three Months Ended								Six Months Ended
		June 30,								June 30,
(Dollars in millions, except for per share amounts)		2023				2022				2023				2022
Numerator:
Net loss available for common stockholders		$	(1.1	)		$	(0.7	)		$	(2.2	)		$	(1.5	)
Denominator:
Weighted average number of common shares outstanding during the period - basic and diluted (in thousands)			26.4				26.4				26.4				26.4
Net loss per common share – basic and diluted		$	(41.66	)		$	(26.52	)		$	(83.33	)		$	(56.82	)

  

Note 4 — Supplemental Balance Sheet Information

 

Additional supplemental balance sheet information is provided as follows:

 

Other current assets were $0.3 million and $0.0 million as of June 30, 2023 and December 31, 2022, respectively (see Note 11 — Fair Value Measurements).

 

Other current liabilities were $0.4 million as of June 30, 2023 and December 31, 2022, and include accruals for payroll expense of $0.2 million and insurance and corporate liability accruals of $0.2 million.

 

8

Table of Contents

 

Note 5 — Arrive Investment

 

Arrive LLC (“Arrive”) is a company that was formed in partnership with Roc Nation with the intent of building a new platform and brand focused on early stage, high growth opportunities. Roc Nation is a full-service entertainment company, inclusive of artist and athlete management, label, publishing, touring, film/TV and new ventures. Arrive seeks to leverage these relationships to invest in proprietary opportunities and provide services including, but not limited to, marketing, promotion or strategic advice for its portfolio investments. The Company holds two separate Arrive investments described below.

 

●

Investment in Arrive of $12.5 million and $12.8 million as of June 30, 2023 and December 31, 2021, respectively, represents an investment in the Arrive operating company, Arrive I LLC. The Company’s investment entitles the Company to appoint one of five Arrive Board members and gives the Company priority for distributions of current income and investment proceeds. In addition, the Company is entitled to receive between 18% and 20% of all general partner consideration on pooled investment vehicles managed by Arrive, whether characterized as management fees or incentive fees.

 

●

Other assets of $0.6 million and $0.5 million as of June 30, 2023 and December 31, 2022, respectively, represent an investment in the Arrive Opportunities Fund I, LP, managed by an affiliate of Arrive I LLC.

 

The Company did not record any unrealized gains or losses during the three months ended June 30, 2023 or 2022 related to these investments. The Company took distributions of $0.3 million from the Arrive operating company, Arrive I LLC, in the form of marketable securities during the six months ended June 30, 2023. The Company is not required to contribute additional capital to either of the investments.

 

Historically, the Company accounted for such investments under the cost method of accounting. The adoption of ASU No. 2016-01 in the first quarter of 2018 effectively eliminated the cost method of accounting, and the carrying value of this investment is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. Our strategic investment in equity securities does not have a readily determinable fair value; therefore, the new guidance was adopted prospectively. As of June 30, 2023, there were no indicators of impairment for this investment. The Company will assess the investment for potential impairment, quarterly.

 

Note 6 — Debt

 

Debt and notes payable consists of the following:

 

		June 30,
		2023				December 31,
		(unaudited)				2022
		(in millions)
GHI LLC note payable		$	3.9			$	3.7
Other liabilities			0.2				0.2
Total long term debt		$	4.1			$	3.9

  

The Company entered into a Term Loan and Security Agreement (“GHI Loan Agreement”) with Gazellek Holdings I, LLC (“GHI LLC”), pursuant to which GHI LLC lent $3,450,000 to the Company on August 6, 2021. The loan bears in-kind interest, quarterly, at the annual rate of 7%, which has the effect of compounding the interest and adding it to the principal amount. The loan is secured by substantially all of the Company’s assets and those of all of its subsidiaries, which are required to guarantee the loan, and matures August 2, 2024.

 

The Company is required to prepay the loan upon receiving proceeds from future indebtedness exceeding $5,000,000 (other than indebtedness that is junior to the loan), or if the Company issues any capital stock (provided that the Company is allowed to retain up to 20% of the proceeds from such issuance). The GHI Loan Agreement contains customary representations and warranties, covenants and events of default. Upon the occurrence of an event of default, the loan bears interest at a rate 5% above the then-effective interest rate and, at GHI LLC’s option, is payable either in cash or in cash and shares of Company common stock, valued at market, equal to up to 10% of the outstanding principal amount of the loan. A default fee equal to 0.5% of the outstanding principal applies if any default exists for 10 days or more.

 

9

Table of Contents

 

Scheduled maturities of the Company’s long-term debt, as they exist as of June 30, 2023, in each of the next five fiscal years and thereafter are as follows:

 

Fiscal years ending in		(in millions)
2023		$	—
2024			3.9
2025			—
2026			—
2027			—
2028 and thereafter			0.2
Total		$	4.1

 

Note 7 — Stock-Based Compensation

 

We have stock-based compensation awards consisting of stock options under the 2011 Incentive Plan, which is described in detail in our Annual Report on Form 10-K for the year ended December 31, 2022. As of June 30, 2023, there are no remaining shares available for grant under the 2011 Incentive Plan. No further shares were available for grant under any other stock incentive plan. The Company did not have any stock-based compensation expense for the three and six months ended June 30, 2023 and 2022.

 

Stock Options

 

The following table summarizes our stock option activity:

 

		Stock Options				Weighted Average Exercise Price
Outstanding December 31, 2022			1,360			$	106.00
Outstanding June 30, 2023			1,360			$	106.00
Exercisable as of June 30, 2023			1,360			$	106.00

 

As of June 30, 2023, options to purchase 1,360 shares are outstanding and exercisable, and the aggregate intrinsic value of all outstanding stock options was $0.0 million. No options were granted or exercised during the three and six months ended June 30, 2023.

 

As of June 30, 2023, there is no unrecognized compensation expense related to outstanding stock options.

 

Note 8 — Income Taxes

 

For interim income tax reporting, we are required to estimate our annual effective tax rate and apply it to year-to-date pre-tax income (loss), excluding unusual or infrequently occurring discrete items. For the three months ended June 30, 2023, we recorded income tax from continuing operations of $0.0 million, on a loss of $1.1 million. For the three months ended June 30, 2022, we recorded income tax from continuing operations of $0.0 million on a loss of $0.7 million. The effective income tax rate for the three months ended June 30, 2023 differs from the U.S. federal statutory rate of 21% primarily due to a valuation allowance on various deferred tax assets.

 

We file income tax returns in multiple jurisdictions that are subject to review by various U.S and state taxing authorities. Our U.S. federal income tax returns for 2019 to present, and certain state returns from 2018 to present, are open to examination.

 

Note 9 — Shareholders’ Equity

 

Treasury Stock

 

On November 14, 2016, our Board authorized a share repurchase program under which we may repurchase up to 2,500 shares of common stock, from time to time, using a variety of methods, which may include open market transactions and privately negotiated transactions.

 

10

Table of Contents

 

The Company did not purchase any shares during the three months ended June 30, 2023. Since the November 14, 2016 authorization, we have repurchased 780 shares of common stock for $0.3 million, and, as of June 30, 2023, we had remaining authorization to repurchase 1,720 additional shares.

 

As of June 30, 2023 and December 31, 2022, the Company has 2,927 shares of treasury stock, acquired at an average price of $8,496.47 per share.

 

Stock Warrants

 

In connection with the GHI Loan Agreement, the Company issued to GHI LLC, for $120,000, a Common Stock Purchase Warrant entitling GHI LLC to purchase 4.8% of GLAE’s outstanding common stock, at the price of $0.01 per share, and a second Common Stock Purchase Warrant entitling GHI LLC to purchase 5.2% of GLAE’s outstanding common stock, at the price of $169.62 per share. The second warrant is automatically canceled if the Company consummates a Sale Transaction that is sourced other than by GHI LLC or its affiliates. A “Sale Transaction” is a merger, consolidation, combination or similar transaction (in one or a series of related transactions), such that the beneficial owners of shares of Company common stock immediately prior to the transaction or transactions will, immediately after such transaction or transactions, beneficially own less than a majority of the shares of common stock or outstanding equity of the surviving corporation (on a fully diluted basis). Each warrant expires August 2, 2026, is exercisable net of proceeds received; entitles its holder to receive certain distributions on the Company’s common stock, as if the warrant had been exercised; and bears registration rights respecting the underlying common stock. The first warrant purports to give its holder voting rights, as if the warrant had been exercised. The sale was exempt from registration under the Securities Act pursuant to Sec. 4(a)(2), as not involving any public offering, because no general solicitation was involved, and GHI LLC is an accredited professional investor, which agreed to accept restricted securities. See Note 6 – Debt for more information on the GHI Loan Agreement.

 

Note 10 — Litigation, Commitments and Contingencies

 

Plaintiff Cypress Holdings, III L.P. (“Cypress”) filed an action against the Company in New York Supreme Court, which was removed to the United States District Court, Southern District of New York, on February 14, 2022, captioned Cypress Holdings, III L.P. v. Sport-BLX, Inc. et al., 1:22-cv-01243-LGS (S.D.N.Y.). In its Second Amended Complaint, Cypress purports to assert claims against SportBLX, Mr. Hall, and Mr. De Perio for securities fraud and related issues and seeks compensatory damages, punitive damages and attorneys’ fees, in connection with solicitations of investments in SportBLX. Cypress also purports to allege that the Company is liable for unjust enrichment, tortious interference with contract, aiding and abetting a breach of fiduciary duty and minority shareholder oppression. Cypress also purports to assert claims against Messrs. Strauss and Ruchalski for breach of fiduciary duty and corporate waste, as well as additional claims against Clinton Group Inc., Cesar Baez, Christopher Johnson, and Sport-BLX Securities, Inc. arising from solicitations of investments in SportBLX.

 

The matter is presently in the discovery phase and the Company along with Messrs. Strauss and Ruchalski, intend to defend themselves vigorously. As of December 31, 2021, GlassBridge Enterprises, Inc. sold all of its interest in SportBLX and SportBLX ceased to be a subsidiary.

 

As of June 30, 2023, the Company believes that an outcome resulting in a loss is remote and does not have any accruals related to the matter.

 

Jimmie D. Dean and Evelyn Dean filed an action against the Company and dozens of other defendants in the 12th Judicial Circuit Court, St. Clair County Illinois (23 LA 0395) asserting claims related to asbestos. Plaintiff alleged that the Company negligently constructed and/or maintained its premises and that Plaintiff was wrongfully exposed to asbestos-containing products while on its premises. Plaintiff further alleged that such activity was a direct and proximate cause of his development and contraction of an asbestos-related disease, including Lung Cancer. Damages alleged are in excess of $50,000.

 

The claim is being made against the Company due to its acquisition of certain assets of Memorex International Inc. in 2006. Such acquisition specifically excluded any undisclosed and contingent liabilities including any litigation that was commenced after closing. Accordingly, counsel to the Company has contacted plaintiff’s counsel to request a voluntary dismissal from the action.

 

As of June 30, 2023, the Company believes that an outcome resulting in a loss is remote and does not have any accruals related to the matter.

 

Indemnification Obligations

 

In the normal course of business, we periodically enter into agreements that incorporate general indemnification language. Performance under these indemnities would generally be triggered by a breach of terms of the contract or by a supportable third-party claim. There has historically been no material losses related to such indemnifications. As of June 30, 2023 and December 31, 2022, estimated liability amounts associated with such indemnifications were not material.

 

11

Table of Contents

 

Note 11 — Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or the exit price in an orderly transaction between market participants on the measurement date. A three-level hierarchy is used for fair value measurements based upon the observability of the inputs to the valuation of an asset or liability as of the measurement date. Level 1 measurements consist of unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 measurements include quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 3 measurements include significant unobservable inputs. A financial instrument’s level within the hierarchy is based on the highest level of any input that is significant to the fair value measurement. The Company measures certain assets and liabilities at their estimated fair value on a recurring basis, including cash and cash equivalents and investments in marketable securities.

 

The following tables present investments measured at fair value:

 

		June 30, 2023
(In millions)		Level 1				Level 2				Level 3				Total
Assets:
Marketable securities		$	0.3			$	—			$	—			$	0.3

 

December 31, 2022

(In millions)

Level 1

Level 2

Level 3

Total

Assets:

Marketable securities

$

—

$

—

$

—

$

—

 

12

Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-Looking Statements and Risk Factors

 

We may from time to time make written or oral forward-looking statements with respect to our future goals, including statements contained in this Form 10-Q, in our other filings with the SEC and in our reports to shareholders.

 

Certain information which does not relate to historical financial information may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include information concerning the launch of our asset management business and related investment vehicles, strategic initiatives and potential acquisitions, the results of operations of our existing business lines, the impact of legal or regulatory matters on our business, as well as other actions, strategies and expectations, and are identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. Such statements are subject to a wide range of risks and uncertainties that could cause our actual results in the future to differ materially from our historical results and those presently anticipated or projected. We wish to caution investors not to place undue reliance on any such forward-looking statements. Any forward-looking statements speak only as of the date on which such statements are made, and we undertake no obligation to update such statements to reflect events or circumstances arising after such date. Risk factors include various factors set forth from time to time in our filings with the SEC including the following: our need for substantial additional capital in order to fund our business; our ability to realize the anticipated benefits of our restructuring plan and other recent significant changes; significant costs relating to pending and future litigation; our ability to attract and retain talented personnel; the structure or success of our participation in any joint investments; risks associated with any future acquisition or business opportunities; our need to consume resources in researching acquisitions, business opportunities or financings and capital market transactions; our ability to integrate additional businesses or technologies; the impact of our reverse stock split on the market trading liquidity of our common stock; the market price volatility of our common stock; our need to incur asset impairment charges for intangible assets; significant changes in discount rates, rates of return on pension assets and mortality tables; our reliance on aging information systems and our ability to protect those systems against security breaches; our ability to integrate accounting systems; changes in tax guidance and related interpretations and inspections by tax authorities; our ability to raise capital from third party investors for our asset management business; our ability to comply with extensive regulations relating to the launch and operation of our asset management business; our ability to compete in the intensely competitive asset management business; the performance of any investment funds we sponsor or accounts we manage; difficult market and economic conditions, including changes in interest rates and volatile equity and credit markets; our ability to achieve steady earnings growth on a quarterly basis in our asset management business; the significant demands placed on our resources and employees, and associated increases in expenses, risks and regulatory oversight, resulting from the potential growth of our asset management business; and our ability to establish a favorable reputation for our asset management business; the lack of operating history of our asset manager subsidiary and any funds that we may sponsor; our ability to develop and deliver differentiated and innovative products.

 

Overview

 

GlassBridge Enterprises, Inc. (“GlassBridge,” the “Company,” “we,” “us,” or “our”) owns and operates an asset management business. We actively explore a diverse range of new, strategic asset management business opportunities for our portfolio.

 

Important Notices and Disclaimers

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to be read in conjunction with our Condensed Consolidated Financial Statements and related Notes that appear elsewhere in this Quarterly Report on Form 10-Q. This MD&A contains forward-looking statements that involve risks and uncertainties. The Company’s actual results could differ materially from those anticipated due to various factors discussed in this MD&A under the caption “Forward-Looking Statements and Risk Factors” and the information contained in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”) on April 7, 2023.

 

This Quarterly Report on Form 10-Q includes tradenames and trademarks owned by us or that we have the right to use. Solely for convenience, the trademarks or tradenames referred to in this Quarterly Report on Form 10-Q may appear without the ® or ™ symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights to these trademarks and tradenames.

 

13

Table of Contents

 

Executive Summary

 

Consolidated Results of Operations for the Three Months Ended June 30, 2023

 

	●	Net revenue was $0.0 million for the three months ended June 30, 2023 and 2022.
	●	Net loss was $1.1 million and $0.7 million for the three months ended June 30, 2023 and 2022, respectively. This was an increase of $0.4 million, primarily due to legal fees in connection with the Cypress lawsuit.
	●	Basic and diluted loss per share from continuing operations was $41.66 for the three months ended June 30, 2023, compared with basic and diluted loss per share of $26.52 for the same period last year.

 

Consolidated Results of Operations for the Six Months Ended June 30, 2023

 

	●	Net revenue was $0.1 million and $0.0 million for the six months ended June 30, 2023 and 2022, respectively.
	●	Net loss was $2.2 million and $1.5 million for the six months ended June 30, 2023 and 2022, respectively. This was an increase of $0.7 million, primarily due to legal fees in connection with the Cypress lawsuit.
	●	Basic and diluted loss per share from continuing operations was $83.33 for the six months ended June 30, 2023, compared with basic and diluted loss per share of $56.82 for the same period last year.

 

Cash Flow/Financial Condition for the Six Months Ended June 30, 2023

 

●

Cash and cash equivalents totaled $0.2 million at June 30, 2023, compared with $1.2 million at December 31, 2022. The decrease in the cash balance of $1.0 million was primarily due to operating expenses.

 

Results of Operations

 

The following discussion relates to continuing operations unless indicated otherwise. “NM” means that the percentage amount is not meaningful.

 

Net Revenue

 

		Three Months Ended												Six Months Ended
		June 30,								Percent				June 30,								Percent
(Dollars in millions)		2023				2022				Change				2023				2022				Change
Net revenue		$	—			$	—				NM			$	0.1			$	—				NM

  

Net revenue was $0.0 million for the three months ended June 30, 2023 and 2022, respectively.

 

Net revenue was $0.1 million and $0.0 million for the six months ended June 30, 2023 and 2022, respectively.

 

Selling, General and Administrative (“SG&A”)

 

		Three Months Ended								Six Months Ended
		June 30,								Percent				June 30,								Percent
(Dollars in millions)		2023				2022				Change				2023				2022				Change
Selling, general and administrative		$	1.1			$	0.8				37.5	%		$	2.2			$	1.6				37.5	%
As a percent of revenue			NM				NM								2,200.0	%			NM

  

SG&A expense increased for the three months ended June 30, 2023 by $0.3 million (or 37.5%), compared with the same period last year, primarily due to legal fees in connection with the Cypress lawsuit. See Note 10 — Litigation, Commitments and Contingencies for more information regarding litigation.

 

SG&A expense increased for the six months ended June 30, 2023 by $0.6 million (or 37.5%), compared with the same period last year, primarily due to legal fees in connection with the Cypress lawsuit. See Note 10 — Litigation, Commitments and Contingencies for more information regarding litigation.

 

14

Table of Contents

 

Operating Loss

 

		Three Months Ended												Six Months Ended
		June 30,								Percent				June 30,								Percent
(Dollars in millions)		2023				2022				Change				2023				2022				Change
Loss from operations		$	(1.1	)		$	(0.8	)			(37.5	)%		$	(2.1	)		$	(1.6	)			(31.3	)%
As a percent of revenue			NM				NM								2,100.0	%			NM

  

Operating loss was $1.1 million and $0.8 million for the three months ended June 30, 2023 and 2022, respectively. Operating loss increased by $0.3 million for the three months ended June 30, 2023, compared with the same period last year, primarily due to legal fees in connection with the Cypress lawsuit. See Note 10 — Litigation, Commitments and Contingencies for more information regarding litigation.

 

Operating loss was $2.1 million and $1.6 million for the six months ended June 30, 2022 and 2021, respectively. Operating loss increased by $0.5 million for the six months ended June 30, 2022, compared with the same period last year, primarily due to legal fees in connection with the Cypress lawsuit. See Note 10 — Litigation, Commitments and Contingencies for more information regarding litigation.

 

Other Income (Expense)

 

		Three Months Ended												Six Months Ended
		June 30,								Percent				June 30,								Percent
(Dollars in millions)		2023				2022				Change				2023				2022				Change
Interest expense		$	(0.1	)		$	—				NM			$	(0.2	)		$	(0.1	)			100.0	%
Other income, net			0.1				0.1				0.0	%			0.1				0.2				(50.0	)%
Total other income		$	—			$	0.1				(100.0	)%		$	(0.1	)		$	0.1				(200.0	)%
As a percent of revenue			NM				NM								(100.0	)%			NM

  

Total other income for the three months ended June 30, 2023 and 2022 was $0.0 million and $0.1 million, respectively.

 

For the six months ended June 30, 2023, total expense was $0.1 million and for the six months ended June 30, 2022, total income was $0.1 million.

 

Income Tax Provision

 

		Three Months Ended												Six Months Ended
		June 30,								Percent				June 30,								Percent
(Dollars in millions)		2023				2022				Change				2023				2022				Change
Income tax benefit (provision)		$	—			$	—				NM			$	—			$	—				NM
Effective tax rate			0.0	%			0.0	%							0.0	%			0.0	%

 

Income tax for the three and six months ended June 30, 2023 and 2022 was $0.0 million, due to losses in the period or loss carryovers from prior periods.

 

Segment Results

 

The asset management business is our only reportable segment as of June 30, 2023.

 

We evaluate segment performance based on revenue and operating loss. The operating loss reported in our segments excludes corporate and other unallocated amounts. Although such amounts are excluded from the business segment results, they are included in reported consolidated results. Corporate and unallocated amounts include costs that are not allocated to the business segments in management’s evaluation of segment performance, such as litigation settlement expense, corporate expense and other expenses.

 

15

Table of Contents

 

Information related to our segment is as follows:

 

Asset Management Business

 

		Three Months Ended												Six Months Ended
		June 30,								Percent				June 30,								Percent
(Dollars in millions)		2023				2022				Change				2023				2022				Change
Operating loss		$	(0.3	)		$	(0.3	)			0.0	%		$	(0.6	)		$	(0.7	)			(14.3	)%

  

The Company operates its diversified private asset management business through a number of subsidiaries that sponsor our fund offerings. We expect our asset management business to earn revenues primarily by providing investment advisory services to third party investors through our managed funds, as well as separate managed accounts.

 

Corporate and Unallocated

 

		Three Months Ended												Six Months Ended
		June 30,								Percent				June 30,								Percent
(Dollars in millions)		2023				2022				Change				2023				2022				Change
Corporate and unallocated operating loss		$	(0.8	)		$	(0.5	)			60.0	%		$	(1.5	)		$	(0.9	)			66.7	%

  

For the three months ended June 30, 2023 and 2022, corporate and unallocated operating loss was $0.8 million and $0.5 million, respectively, representing a 60.0% increase from the prior year. The increase is primarily due to legal fees in connection with the Cypress lawsuit. See Note 10 — Litigation, Commitments and Contingencies for more information regarding litigation.

 

For the six months ended June 30, 2023 and 2022, corporate and unallocated operating loss was $1.5 million and $0.9 million, respectively, representing a 66.7% increase from the prior year. The increase is primarily due to legal fees in connection with the Cypress lawsuit. See Note 10 — Litigation, Commitments and Contingencies for more information regarding litigation.

 

Impact of Changes in Foreign Currency Rates

 

The impact of changes in foreign currency exchange rates to worldwide revenue was immaterial for the three and six months ended June 30, 2023.

 

Financial Position

 

Our cash and cash equivalents balance as of June 30, 2023 was $0.2 million, compared to $1.2 million as of December 31, 2022.

 

Our accounts payable balance as of June 30, 2023 was $2.2 million, compared to $1.2 million as of December 31, 2022.

 

Our other current liabilities balance as of June 30, 2023 and December 31, 2022 was $0.4 million.

 

Liquidity and Capital Resources

 

Cash Flows Used in Operating Activities:

 

		Six Months Ended
		June 30,
(Dollars in millions)		2023				2022
Net loss		$	(2.2	)		$	(1.5	)
Adjustments to reconcile net loss to net cash used in operating activities:
Payment-in-Kind interest			0.2				0.1
Changes in operating assets and liabilities			1.0				0.1
Net cash used in operating activities		$	(1.0	)		$	(1.3	)

  

Cash used in operating activities was $1.0 million and $1.3 million for the three months ended June 30, 2023 and 2022, respectively, which was primarily related to ordinary operating expenses.

 

16

Table of Contents

 

Cash Flows Used In Investing Activities:

 

		Six Months Ended
		June 30,
(Dollars in millions)		2023				2022
Purchase of investments		$	—			$	(0.2	)
Net cash used in investing activities		$	—			$	(0.2	)

 

Investing activities for the six months ended June 30, 2022 included a $0.2 million contribution to the Arrive investment.

 

Cash Flows Provided by Financing Activities:

 

		Six Months Ended
		June 30,
(Dollars in millions)		2023				2022
Net cash provided by financing activities		$	—			$	—

 

The Company had no cash provided by financing activities for the six months ended June 30, 2023 or 2022.

 

We have various resources available to us for purposes of managing liquidity and capital needs. Our primary sources of liquidity include our cash and cash equivalents. Our primary liquidity needs relate to funding our operations.

 

We had $0.2 million cash and cash equivalents on hand as of June 30, 2023.

 

We expect that our cash, in addition to asset monetization, will provide liquidity sufficient to meet our needs for our operations and our obligations. We also plan to raise additional capital if necessary, although no assurance can be made that we will be able to secure such financing, if needed, on favorable terms or at all.

 

17

Table of Contents

 

Off Balance Sheet Arrangements

 

As of June 30, 2023, we did not have any material off-balance sheet arrangements.

 

Critical Accounting Policies and Estimates

 

A discussion of the Company’s critical accounting policies was provided in Part II — Item 7 in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

 

Recent Accounting Pronouncements

 

See Note 2 - New Accounting Pronouncements in our Notes to Condensed Consolidated Financial Statements in Part I, Item 1, herein, for further information.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide the information required under this item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Based on an evaluation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of June 30, 2023, the end of the period covered by this report, the Chief Executive Officer, Daniel Strauss, and the Chief Financial Officer, Francis Ruchalski, have concluded that the disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of June 30, 2023, based on the guidelines established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO 2013). Our internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles. During the quarter ended June 30, 2023, management concluded there was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(e) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

18

Table of Contents

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

See Note 10 - Litigation, Commitments and Contingencies in our Notes to Condensed Consolidated Financial Statements in Part I, Item 1 herein for further information regarding our legal proceedings.

 

The Company is subject to various lawsuits, claims and other legal matters that arise in the ordinary course of conducting business (including litigation relating to our legacy businesses and discontinued operations). All such matters involve uncertainty and, accordingly, outcomes that cannot be predicted with assurance. As of June 30, 2023, we are unable to estimate with certainty the ultimate aggregate amount of monetary liability or financial impact that we may incur with respect to these matters. It is reasonably possible that the ultimate resolution of these matters, individually or in the aggregate, could materially affect our financial condition, results of the operations and cash flows. Similarly, the Company is the plaintiff in a number of matters in the United States and elsewhere where the potential outcomes could be materially beneficial to the Company. These outcomes are also uncertain.

 

Item 1A. Risk Factors.

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide the information required under this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Not applicable.

 

Item 3. Defaults Upon Senior Securities.

 

Not applicable.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Not applicable.

 

Item 6. Exhibits.

 

The following documents are filed as part of, or incorporated by reference into, this report:

 

Exhibit Number		Description of Exhibit
31.1		Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101		The following financial information from GlassBridge Enterprises, Inc.’s Quarterly Report on Form 10-Q for the period ended June 30, 2023, formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Operations, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to Condensed Consolidated Financial Statements.

 

19

Table of Contents

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

			GLASSBRIDGE ENTERPRISES, INC.
Date:	August 14, 2023		By:	/s/ Francis Ruchalski
			Name:	Francis Ruchalski
			Title:	Chief Financial Officer (duly authorized officer and principal financial officer)

 

20

 

 

Exhibit 31.1

 

Certification Pursuant to Section 302

of the Sarbanes-Oxley Act of 2002

 

I, Daniel Strauss, certify that:

 

	1.	I have reviewed this quarterly report on Form 10-Q of GlassBridge Enterprises, Inc.;
	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
	4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a -15(e) and 15d -15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

August 14, 2023

 

By:	/s/ Daniel Strauss
	Daniel Strauss
	Chief Executive Officer

 

 

Exhibit 31.2

 

Certification Pursuant to Section 302

of the Sarbanes-Oxley Act of 2002

 

I, Francis Ruchalski, certify that:

 

	1.	I have reviewed this quarterly report on Form 10-Q of GlassBridge Enterprises, Inc.;
	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
	4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a -15(e) and 15d -15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a -15(f) and 15d -15(f)) for the registrant and have:

 

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
	(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

August 14, 2023

 

By:	/s/ Francis Ruchalski
	Francis Ruchalski
	Chief Financial Officer

 

 

 

Exhibit 32.1

 

Certification Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of GlassBridge Enterprises, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Daniel Strauss, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

 

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

August 14, 2023

 

By:	/s/ Daniel Strauss
	Daniel Strauss
	Chief Executive Officer

 

 

Exhibit 32.2

 

Certification Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report of GlassBridge Enterprises, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023, as filed with the Securities and Exchange Commission (the “Report”), I, Francis Ruchalski, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

 

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

August 14, 2023

 

By:	/s/ Francis Ruchalski
	Francis Ruchalski
	Chief Financial Officer

 

 

Cover - shares	6 Months Ended
	Jun. 30, 2023	Jul. 31, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	1-14310
Entity Registrant Name	GLASSBRIDGE ENTERPRISES, INC.
Entity Central Index Key	0001014111
Entity Tax Identification Number	41-1838504
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	18 East 50th Street
Entity Address, Address Line Two	FL7
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	(212)
Local Phone Number	220-3300
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		25,170

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Income Statement [Abstract]
Net revenue			$ 0.1
Operating expenses:
Selling, general and administrative	1.1	0.8	2.2	1.6
Total operating expenses	1.1	0.8	2.2	1.6
Operating loss	(1.1)	(0.8)	(2.1)	(1.6)
Other income (expense):
Interest expense	(0.1)		(0.2)	(0.1)
Other income, net	0.1	0.1	0.1	0.2
Total other income (expense)		0.1	(0.1)	0.1
Loss before income taxes	(1.1)	(0.7)	(2.2)	(1.5)
Net loss	$ (1.1)	$ (0.7)	$ (2.2)	$ (1.5)
Net loss per common share — basic and diluted:
Earnings Per Share, Basic	$ (41.66)	$ (26.52)	$ (83.33)	$ (56.82)
Earnings Per Share, Diluted	$ (41.66)	$ (26.52)	$ (83.33)	$ (56.82)
Weighted average common shares outstanding:
Basic (thousands)	26,400	26,400	26,400	26,400
Diluted (thousands)	26,400	26,400	26,400	26,400

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 0.2	$ 1.2
Accounts receivable, net		0.1
Other current assets	0.3
Total current assets	0.5	1.3
Investment in Arrive, cost (See Note 5 – Arrive Investment)	12.5	12.8
Other assets and other investments (See Note 5 – Arrive Investment)	0.6	0.5
Total assets	13.6	14.6
Current liabilities:
Accounts payable	2.2	1.2
Other current liabilities	0.4	0.4
Total current liabilities	2.6	1.6
GHI LLC note payable (See Note 6 – Debt)	3.9	3.7
Deferred tax liabilities	0.2	0.2
Total liabilities	6.7	5.5
Shareholders’ equity:
Preferred stock, $.01 par value, authorized 200,000 shares, none issued and outstanding
Common stock, $.01 par value, authorized 50,000, 28,097 issued at June 30, 2023; 28,097 issued at December 31, 2022
Additional paid-in capital	1,073.0	1,073.0
Accumulated deficit	(1,041.2)	(1,039.0)
Treasury stock, at cost: 2,927 shares at June 30, 2023; 2,927 shares at December 31, 2022	(24.9)	(24.9)
Total shareholders’ equity	6.9	9.1
Total liabilities and shareholders’ equity	$ 13.6	$ 14.6

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	200,000	200,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	50,000	50,000
Common stock, shares issued	28,097	28,097
Treasury stock shares	2,927	2,927

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Total
Balance, value at Dec. 31, 2021		$ 1,073.0	$ (1,036.0)	$ (24.9)	$ 12.1
Balance, shares at Dec. 31, 2021	28,097			2,927
Net loss			(1.5)		(1.5)
Balance, value at Jun. 30, 2022		1,073.0	(1,037.5)	$ (24.9)	10.6
Balance, shares at Jun. 30, 2022	28,097			2,927
Balance, value at Dec. 31, 2022		1,073.0	(1,039.0)	$ (24.9)	9.1
Balance, shares at Dec. 31, 2022	28,097			2,927
Net loss			(2.2)		(2.2)
Balance, value at Jun. 30, 2023		$ 1,073.0	$ (1,041.2)	$ (24.9)	$ 6.9
Balance, shares at Jun. 30, 2023	28,097			2,927

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net loss	$ (2.2)	$ (1.5)
Adjustments to reconcile net loss to net cash used in operating activities:
Payment-in-Kind interest	0.2	0.1
Changes in operating assets and liabilities	1.0	0.1
Net cash used in operating activities	(1.0)	(1.3)
Cash Flows from Investing Activities:
Purchase of investments		(0.2)
Net cash used in investing activities		(0.2)
Cash Flows from Financing Activities:
Net cash provided by financing activities
Net change in cash and cash equivalents	(1.0)	(1.5)
Cash and cash equivalents — beginning of period	1.2	4.1
Cash and cash equivalents — end of period	0.2	2.6
Supplemental disclosures of cash paid during the period:
Interest expense		0.1
Non-cash investing and financing activities during the period:
Marketable securities received from Arrive distribution	0.3
Offset accounts receivable from Arrive vs capital contribution due Arrive	$ 0.1

Basis of Presentation	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Note 1 — Basis of Presentation   GlassBridge Enterprises, Inc. (“GlassBridge”, the “Company”, “we”, “us” or “our”) owns and operates an asset management business through various subsidiaries.   The interim Condensed Consolidated Financial Statements of GlassBridge are unaudited but, in the opinion of management, reflect all adjustments necessary for a fair statement of financial position, results of operations, comprehensive loss and cash flows for the periods presented. Except as otherwise disclosed herein, these adjustments consist of normal and recurring items. The results of operations for any interim period are not necessarily indicative of full year results. The Condensed Consolidated Financial Statements and Notes are presented in accordance with the requirements for Quarterly Reports on Form 10-Q and do not contain certain information included in our annual Consolidated Financial Statements and Notes presented in accordance with the requirements of Annual Reports on Form 10-K.   The interim Condensed Consolidated Financial Statements include the accounts of the Company, its wholly-owned subsidiaries, and entities in which the Company owns or controls fifty percent or more of the voting shares or interest in such entity, and has the right to control. The results of entities disposed of are included in the unaudited Condensed Consolidated Financial Statements up to the date of the disposal and, where appropriate, these operations have been reflected as discontinued operations. All inter-company balances and transactions have been eliminated in consolidation and, in the opinion of management, all adjustments necessary for a fair presentation have been included in the interim results reported.   The preparation of the interim Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim Condensed Consolidated Financial Statements and the reported amounts of revenue and expenses for the reporting periods. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.   The December 31, 2022 Condensed Consolidated Balance Sheet data was derived from the audited Consolidated Financial Statements, but does not include all disclosures required by GAAP. This Form 10-Q should be read in conjunction with our Consolidated Financial Statements and Notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the U.S. Securities and Exchange Commission on April 7, 2023.

New Accounting Pronouncements	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
New Accounting Pronouncements	Note 2 — New Accounting Pronouncements   The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its consolidated financial position or results of operations.

Income (Loss) per Common Share	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Income (Loss) per Common Share	Note 3 —Income (Loss) per Common Share   Basic income per common share is calculated using the weighted average number of shares outstanding for the period. Unvested restricted stock and treasury shares are excluded from the calculation of weighted average number of common shares outstanding in all cases. Once restricted stock vests, it is included in our common shares outstanding.   Diluted income per common share is computed on the basis of the weighted average shares outstanding plus the dilutive effect of our stock-based compensation plans, using the “treasury stock” method.   The Company has 1,360 shares of outstanding and exercisable stock options that have been excluded because they would be anti-dilutive. See Note 7 –Stock-Based Compensation for additional information on the stock options.     The following table sets forth the computation of weighted average basic and diluted income per share (unaudited):       Three Months Ended     Six Months Ended       June 30,     June 30,   (Dollars in millions, except for per share amounts)   2023     2022     2023     2022   Numerator:                                 Net loss available for common stockholders   $ (1.1 )   $ (0.7 )   $ (2.2 )   $ (1.5 ) Denominator:                                 Weighted average number of common shares outstanding during the period - basic and diluted (in thousands)     26.4       26.4       26.4       26.4                                     Net loss per common share – basic and diluted   $ (41.66 )   $ (26.52 )   $ (83.33 )   $ (56.82 )

Supplemental Balance Sheet Information	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Balance Sheet Information	Note 4 — Supplemental Balance Sheet Information   Additional supplemental balance sheet information is provided as follows:   Other current assets were $0.3 million and $0.0 million as of June 30, 2023 and December 31, 2022, respectively (see Note 11 — Fair Value Measurements).   Other current liabilities were $0.4 million as of June 30, 2023 and December 31, 2022, and include accruals for payroll expense of $0.2 million and insurance and corporate liability accruals of $0.2 million.

Arrive Investment	6 Months Ended
	Jun. 30, 2023
Investments, All Other Investments [Abstract]
Arrive Investment	Note 5 — Arrive Investment   Arrive LLC (“Arrive”) is a company that was formed in partnership with Roc Nation with the intent of building a new platform and brand focused on early stage, high growth opportunities. Roc Nation is a full-service entertainment company, inclusive of artist and athlete management, label, publishing, touring, film/TV and new ventures. Arrive seeks to leverage these relationships to invest in proprietary opportunities and provide services including, but not limited to, marketing, promotion or strategic advice for its portfolio investments. The Company holds two separate Arrive investments described below.   ● Investment in Arrive of $12.5 million and $12.8 million as of June 30, 2023 and December 31, 2021, respectively, represents an investment in the Arrive operating company, Arrive I LLC. The Company’s investment entitles the Company to appoint one of five Arrive Board members and gives the Company priority for distributions of current income and investment proceeds. In addition, the Company is entitled to receive between 18% and 20% of all general partner consideration on pooled investment vehicles managed by Arrive, whether characterized as management fees or incentive fees.   ● Other assets of $0.6 million and $0.5 million as of June 30, 2023 and December 31, 2022, respectively, represent an investment in the Arrive Opportunities Fund I, LP, managed by an affiliate of Arrive I LLC.   The Company did not record any unrealized gains or losses during the three months ended June 30, 2023 or 2022 related to these investments. The Company took distributions of $0.3 million from the Arrive operating company, Arrive I LLC, in the form of marketable securities during the six months ended June 30, 2023. The Company is not required to contribute additional capital to either of the investments.   Historically, the Company accounted for such investments under the cost method of accounting. The adoption of ASU No. 2016-01 in the first quarter of 2018 effectively eliminated the cost method of accounting, and the carrying value of this investment is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. Our strategic investment in equity securities does not have a readily determinable fair value; therefore, the new guidance was adopted prospectively. As of June 30, 2023, there were no indicators of impairment for this investment. The Company will assess the investment for potential impairment, quarterly.

Debt	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Debt	Note 6 — Debt   Debt and notes payable consists of the following:       June 30,           2023     December 31,       (unaudited)     2022       (in millions)   GHI LLC note payable   $ 3.9     $ 3.7   Other liabilities     0.2       0.2   Total long term debt   $ 4.1     $ 3.9      The Company entered into a Term Loan and Security Agreement (“GHI Loan Agreement”) with Gazellek Holdings I, LLC (“GHI LLC”), pursuant to which GHI LLC lent $3,450,000 to the Company on August 6, 2021. The loan bears in-kind interest, quarterly, at the annual rate of 7%, which has the effect of compounding the interest and adding it to the principal amount. The loan is secured by substantially all of the Company’s assets and those of all of its subsidiaries, which are required to guarantee the loan, and matures August 2, 2024.   The Company is required to prepay the loan upon receiving proceeds from future indebtedness exceeding $5,000,000 (other than indebtedness that is junior to the loan), or if the Company issues any capital stock (provided that the Company is allowed to retain up to 20% of the proceeds from such issuance). The GHI Loan Agreement contains customary representations and warranties, covenants and events of default. Upon the occurrence of an event of default, the loan bears interest at a rate 5% above the then-effective interest rate and, at GHI LLC’s option, is payable either in cash or in cash and shares of Company common stock, valued at market, equal to up to 10% of the outstanding principal amount of the loan. A default fee equal to 0.5% of the outstanding principal applies if any default exists for 10 days or more.     Scheduled maturities of the Company’s long-term debt, as they exist as of June 30, 2023, in each of the next five fiscal years and thereafter are as follows:   Fiscal years ending in   (in millions)   2023   $ —   2024     3.9   2025     —   2026     —   2027     —   2028 and thereafter     0.2   Total   $ 4.1

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Note 7 — Stock-Based Compensation   We have stock-based compensation awards consisting of stock options under the 2011 Incentive Plan, which is described in detail in our Annual Report on Form 10-K for the year ended December 31, 2022. As of June 30, 2023, there are no remaining shares available for grant under the 2011 Incentive Plan. No further shares were available for grant under any other stock incentive plan. The Company did not have any stock-based compensation expense for the three and six months ended June 30, 2023 and 2022.   Stock Options   The following table summarizes our stock option activity:       Stock Options   Weighted Average Exercise Price Outstanding December 31, 2022     1,360     $ 106.00   Outstanding June 30, 2023     1,360     $ 106.00   Exercisable as of June 30, 2023     1,360     $ 106.00     As of June 30, 2023, options to purchase 1,360 shares are outstanding and exercisable, and the aggregate intrinsic value of all outstanding stock options was $0.0 million. No options were granted or exercised during the three and six months ended June 30, 2023.   As of June 30, 2023, there is no unrecognized compensation expense related to outstanding stock options.

Income Taxes	6 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Note 8 — Income Taxes   For interim income tax reporting, we are required to estimate our annual effective tax rate and apply it to year-to-date pre-tax income (loss), excluding unusual or infrequently occurring discrete items. For the three months ended June 30, 2023, we recorded income tax from continuing operations of $0.0 million, on a loss of $1.1 million. For the three months ended June 30, 2022, we recorded income tax from continuing operations of $0.0 million on a loss of $0.7 million. The effective income tax rate for the three months ended June 30, 2023 differs from the U.S. federal statutory rate of 21% primarily due to a valuation allowance on various deferred tax assets.   We file income tax returns in multiple jurisdictions that are subject to review by various U.S and state taxing authorities. Our U.S. federal income tax returns for 2019 to present, and certain state returns from 2018 to present, are open to examination.

Shareholders’ Equity	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Shareholders’ Equity	Note 9 — Shareholders’ Equity   Treasury Stock   On November 14, 2016, our Board authorized a share repurchase program under which we may repurchase up to 2,500 shares of common stock, from time to time, using a variety of methods, which may include open market transactions and privately negotiated transactions.     The Company did not purchase any shares during the three months ended June 30, 2023. Since the November 14, 2016 authorization, we have repurchased 780 shares of common stock for $0.3 million, and, as of June 30, 2023, we had remaining authorization to repurchase 1,720 additional shares.   As of June 30, 2023 and December 31, 2022, the Company has 2,927 shares of treasury stock, acquired at an average price of $8,496.47 per share.   Stock Warrants   In connection with the GHI Loan Agreement, the Company issued to GHI LLC, for $120,000, a Common Stock Purchase Warrant entitling GHI LLC to purchase 4.8% of GLAE’s outstanding common stock, at the price of $0.01 per share, and a second Common Stock Purchase Warrant entitling GHI LLC to purchase 5.2% of GLAE’s outstanding common stock, at the price of $169.62 per share. The second warrant is automatically canceled if the Company consummates a Sale Transaction that is sourced other than by GHI LLC or its affiliates. A “Sale Transaction” is a merger, consolidation, combination or similar transaction (in one or a series of related transactions), such that the beneficial owners of shares of Company common stock immediately prior to the transaction or transactions will, immediately after such transaction or transactions, beneficially own less than a majority of the shares of common stock or outstanding equity of the surviving corporation (on a fully diluted basis). Each warrant expires August 2, 2026, is exercisable net of proceeds received; entitles its holder to receive certain distributions on the Company’s common stock, as if the warrant had been exercised; and bears registration rights respecting the underlying common stock. The first warrant purports to give its holder voting rights, as if the warrant had been exercised. The sale was exempt from registration under the Securities Act pursuant to Sec. 4(a)(2), as not involving any public offering, because no general solicitation was involved, and GHI LLC is an accredited professional investor, which agreed to accept restricted securities. See Note 6 – Debt for more information on the GHI Loan Agreement.

Litigation, Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Litigation, Commitments and Contingencies	Note 10 — Litigation, Commitments and Contingencies   Plaintiff Cypress Holdings, III L.P. (“Cypress”) filed an action against the Company in New York Supreme Court, which was removed to the United States District Court, Southern District of New York, on February 14, 2022, captioned Cypress Holdings, III L.P. v. Sport-BLX, Inc. et al., 1:22-cv-01243-LGS (S.D.N.Y.). In its Second Amended Complaint, Cypress purports to assert claims against SportBLX, Mr. Hall, and Mr. De Perio for securities fraud and related issues and seeks compensatory damages, punitive damages and attorneys’ fees, in connection with solicitations of investments in SportBLX. Cypress also purports to allege that the Company is liable for unjust enrichment, tortious interference with contract, aiding and abetting a breach of fiduciary duty and minority shareholder oppression. Cypress also purports to assert claims against Messrs. Strauss and Ruchalski for breach of fiduciary duty and corporate waste, as well as additional claims against Clinton Group Inc., Cesar Baez, Christopher Johnson, and Sport-BLX Securities, Inc. arising from solicitations of investments in SportBLX.   The matter is presently in the discovery phase and the Company along with Messrs. Strauss and Ruchalski, intend to defend themselves vigorously. As of December 31, 2021, GlassBridge Enterprises, Inc. sold all of its interest in SportBLX and SportBLX ceased to be a subsidiary.   As of June 30, 2023, the Company believes that an outcome resulting in a loss is remote and does not have any accruals related to the matter.   Jimmie D. Dean and Evelyn Dean filed an action against the Company and dozens of other defendants in the 12th Judicial Circuit Court, St. Clair County Illinois (23 LA 0395) asserting claims related to asbestos. Plaintiff alleged that the Company negligently constructed and/or maintained its premises and that Plaintiff was wrongfully exposed to asbestos-containing products while on its premises. Plaintiff further alleged that such activity was a direct and proximate cause of his development and contraction of an asbestos-related disease, including Lung Cancer. Damages alleged are in excess of $50,000.   The claim is being made against the Company due to its acquisition of certain assets of Memorex International Inc. in 2006. Such acquisition specifically excluded any undisclosed and contingent liabilities including any litigation that was commenced after closing. Accordingly, counsel to the Company has contacted plaintiff’s counsel to request a voluntary dismissal from the action.   As of June 30, 2023, the Company believes that an outcome resulting in a loss is remote and does not have any accruals related to the matter.   Indemnification Obligations   In the normal course of business, we periodically enter into agreements that incorporate general indemnification language. Performance under these indemnities would generally be triggered by a breach of terms of the contract or by a supportable third-party claim. There has historically been no material losses related to such indemnifications. As of June 30, 2023 and December 31, 2022, estimated liability amounts associated with such indemnifications were not material.

Fair Value Measurements	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 11 — Fair Value Measurements   Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or the exit price in an orderly transaction between market participants on the measurement date. A three-level hierarchy is used for fair value measurements based upon the observability of the inputs to the valuation of an asset or liability as of the measurement date. Level 1 measurements consist of unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 measurements include quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 3 measurements include significant unobservable inputs. A financial instrument’s level within the hierarchy is based on the highest level of any input that is significant to the fair value measurement. The Company measures certain assets and liabilities at their estimated fair value on a recurring basis, including cash and cash equivalents and investments in marketable securities.   The following tables present investments measured at fair value:       June 30, 2023   (In millions)   Level 1     Level 2     Level 3     Total   Assets:                                 Marketable securities   $ 0.3     $ —     $ —     $ 0.3         December 31, 2022   (In millions)   Level 1     Level 2     Level 3     Total   Assets:                         Marketable securities   $ —     $ —     $ —     $ —

Income (Loss) per Common Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of Computation of Weighted Average Basic and Diluted Income (Loss) Per Share	The following table sets forth the computation of weighted average basic and diluted income per share (unaudited):       Three Months Ended     Six Months Ended       June 30,     June 30,   (Dollars in millions, except for per share amounts)   2023     2022     2023     2022   Numerator:                                 Net loss available for common stockholders   $ (1.1 )   $ (0.7 )   $ (2.2 )   $ (1.5 ) Denominator:                                 Weighted average number of common shares outstanding during the period - basic and diluted (in thousands)     26.4       26.4       26.4       26.4                                     Net loss per common share – basic and diluted   $ (41.66 )   $ (26.52 )   $ (83.33 )   $ (56.82 )

Debt (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt and Notes Payable	Debt and notes payable consists of the following:       June 30,           2023     December 31,       (unaudited)     2022       (in millions)   GHI LLC note payable   $ 3.9     $ 3.7   Other liabilities     0.2       0.2   Total long term debt   $ 4.1     $ 3.9
Schedule of Long-term Debt Maturities	Scheduled maturities of the Company’s long-term debt, as they exist as of June 30, 2023, in each of the next five fiscal years and thereafter are as follows:   Fiscal years ending in   (in millions)   2023   $ —   2024     3.9   2025     —   2026     —   2027     —   2028 and thereafter     0.2   Total   $ 4.1

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	The following table summarizes our stock option activity:       Stock Options   Weighted Average Exercise Price Outstanding December 31, 2022     1,360     $ 106.00   Outstanding June 30, 2023     1,360     $ 106.00   Exercisable as of June 30, 2023     1,360     $ 106.00

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Investments measured at Fair Value	The following tables present investments measured at fair value:       June 30, 2023   (In millions)   Level 1     Level 2     Level 3     Total   Assets:                                 Marketable securities   $ 0.3     $ —     $ —     $ 0.3         December 31, 2022   (In millions)   Level 1     Level 2     Level 3     Total   Assets:                         Marketable securities   $ —     $ —     $ —     $ —

Schedule of Computation of Weighted Average Basic and Diluted Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Earnings Per Share [Abstract]
Net loss available for common stockholders	$ (1.1)	$ (0.7)	$ (2.2)	$ (1.5)
Weighted average number of common shares outstanding during the period - basic	26,400	26,400	26,400	26,400
Weighted average number of common shares outstanding during the period - diluted	26,400	26,400	26,400	26,400
Net loss per common share - basic	$ (41.66)	$ (26.52)	$ (83.33)	$ (56.82)
Net loss per common share - diluted	$ (41.66)	$ (26.52)	$ (83.33)	$ (56.82)

Income (Loss) per Common Share (Details Narrative) - shares	Jun. 30, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Number of shares outstanding	1,360	1,360

Supplemental Balance Sheet Information (Details Narrative) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Other current assets	$ 0.3
Other current liabilities	0.4	0.4
Accruals liabilities	$ 0.2	$ 0.2

Arrive Investment (Details Narrative) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Investments, All Other Investments [Abstract]
Investment	$ 12.5		$ 12.8	$ 12.8
Management fee description	the Company is entitled to receive between 18% and 20% of all general partner consideration on pooled investment vehicles managed by Arrive, whether characterized as management fees or incentive fees.
Other assets	$ 0.6		$ 0.5
Marketable securities	$ 0.3

Schedule of Debt and Notes Payable (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Short-Term Debt [Line Items]
Total long term debt	$ 4.1	$ 3.9
GHILLC Note Payable [Member]
Short-Term Debt [Line Items]
Total long term debt	3.9	3.7
Other Liabilities [Member]
Short-Term Debt [Line Items]
Total long term debt	$ 0.2	$ 0.2

Schedule of Long-term Debt Maturities (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
2023
2024	3.9
2025
2026
2027
2028 and thereafter	0.2
Total	$ 4.1	$ 3.9

Debt (Details Narrative) - GHI Loan Agreement [Member]	Aug. 06, 2021 USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from indebtedness	$ 5,000,000
Debt description	Upon the occurrence of an event of default, the loan bears interest at a rate 5% above the then-effective interest rate and, at GHI LLC’s option, is payable either in cash or in cash and shares of Company common stock, valued at market, equal to up to 10% of the outstanding principal amount of the loan. A default fee equal to 0.5% of the outstanding principal applies if any default exists for 10 days or more.
Gazellek Holdings I, LLC [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt instrument, face amount	$ 3,450,000
Debt interest bear percentage	7.00%
Debt maturity date	Aug. 02, 2024

Summary of Stock Option Activity (Details) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock Options, Outstanding	1,360	1,360
Weighted Average Exercise Price, Outstanding	$ 106.00	$ 106.00
Stock Options, Exercisable	1,360
Weighted Average Exercise Price, Exercisable	$ 106.00

Stock-Based Compensation (Details Narrative) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Stock options outstanding	1,360	1,360	1,360
Aggregate intrinsic value of outstanding stock options	$ 0.0	$ 0.0
Number of options exercised	0	0

Income Taxes (Details Narrative) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income tax benefit	$ 0.0	$ 0.0
Income (loss) from continuing operations	$ 1.1	$ 0.7
Federal statutory income tax rate	21.00%

Shareholders’ Equity (Details Narrative) - USD ($)		3 Months Ended	6 Months Ended	12 Months Ended
	Aug. 06, 2021	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Nov. 14, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase of treasury stock, shares		0
Treasury Stock, Common [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Purchase of treasury stock, shares			780
Purchase of treasury stock, value			$ 300,000
Additional number of shares authorized to repurchased		1,720	1,720
Purchase of treasury stock			2,927	2,927
Average price per share of treasury stock acquired			$ 8,496.47	$ 8,496.47
Treasury Stock, Common [Member] | Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares authorized to repurchased					2,500
Common Stock Warrant [Member] | Gazellek Holdings I, LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock issued during period, value, new issues	$ 120,000
Percentage of outstanding stock	4.80%
Shares price	$ 0.01
Warrant maturity dtate	Aug. 02, 2026
Second Common Stock Warrant [Member] | Gazellek Holdings I, LLC [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Percentage of outstanding stock	5.20%
Shares price	$ 169.62

Litigation, Commitments and Contingencies (Details Narrative)	6 Months Ended
	Jun. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Litigation damages value	$ 50,000

Schedule of Investments measured at Fair Value (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 0.3
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0.3
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities

---